CIK 0001824893
- Non-accelerated filer
- Smaller reporting company
Surrozen, Inc./DE
Sign in to watch- Ticker
- SRZN
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 301374889
- Phone
- +1 650-475-2820
- Business address
- 171 OYSTER POINT BLVD, SUITE 400, SOUTH SAN FRANCISCO, CA, 94080
- Former names
- Consonance-HFW Acquisition Corp.
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2022-10-10 | Parker Craig C Chief Executive Officer | Grant or award · Option (right to buy) | +181,270 | 181,270 | ||
| 2022-10-10 | Parker Craig C Chief Executive Officer | Grant or award · Option (right to buy) | +2,065 | 2,065 | ||
| 2022-07-01 | Yeh Wen-Chen Chief Scientific Officer | Grant or award · Option (right to buy) | +500 | 500 | ||
| 2022-06-07 | Kutzkey Tim Director | Grant or award · Option (right to buy) | +20,000 | 20,000 | ||
| 2022-06-07 | CHAI CHRISTOPHER Y Director | Grant or award · Option (right to buy) | +20,000 | 20,000 | ||
| 2022-06-07 | Haak-Frendscho Mary Director | Grant or award · Option (right to buy) | +20,000 | 20,000 | ||
| 2022-06-07 | WOODHOUSE DAVID J Director | Grant or award · Option (right to buy) | +20,000 | 20,000 | ||
| 2022-06-07 | Rothenberg Mace Director | Grant or award · Option (right to buy) | +20,000 | 20,000 | ||
| 2022-06-07 | Lin Shao-Lee Director | Grant or award · Option (right to buy) | +20,000 | 20,000 | ||
| 2022-06-07 | Berkenblit Anna Director | Grant or award · Option (right to buy) | +20,000 | 20,000 | ||
| 2022-03-01 | Yeh Wen-Chen Chief Scientific Officer | Grant or award · Option (right to buy) | +125,000 | 125,000 | ||
| 2022-03-01 | Parker Craig C Chief Executive Officer | Grant or award · Stock Option (right to buy) | +370,000 | 370,000 | ||
| 2022-03-01 | Williams Charles O Chief Financial Officer | Grant or award · Option (right to buy) | +125,000 | 125,000 | ||
| 2022-03-01 | Vanhove Geertrui Chief Medical Officer | Grant or award · Option Grant (right to buy) | +125,000 | $3.11 | $389K | 125,000 |
| 2021-08-12 | Parker Craig C Chief Executive Officer | Grant or award · Stock Option (right to buy) | +183,335 | 183,335 | ||
| 2021-08-12 | Vanhove Geertrui Chief Medical Officer | Grant or award · Employee Stock Option (right to buy) | +36,647 | 36,647 | ||
| 2021-08-12 | Williams Charles O Chief Financial Officer | Grant or award · Employee Stock Option (right to buy) | +14,597 | 14,597 | ||
| 2021-08-11 | Consonance Life Sciences Former 10% Holder | Returned to the company | −434,000 | 0 | ||
| 2021-08-11 | Consonance Life Sciences Former 10% Holder | Other disposition | −759,000 | 1,451,000 | ||
| 2021-08-11 | Consonance Life Sciences Former 10% Holder | Returned to the company | −1,451,000 | 0 |
Page 15 of 20 · 398 trades